¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"African study monographs."¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
family study
°¡Á·Á¶»ç
longitudinal study
ÃßÀû¿¬±¸
molecular genetic study
ºÐÀÚÀ¯ÀüÇа˻ç
neurophysiological study
½Å°æ»ý¸®ÇÐÀû°Ë»ç
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ¿¬±¸
population study
Àα¸Á¶»ç
preclinical study
ÀÓ»óÀü½ÃÇè, ÀüÀӻ󿬱¸
pressure flow study
¾Ð·Â¿ä·ù°Ë»ç
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸
real time study
½Ç½Ã°£°Ë»ç
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸
study
1. ¿¬±¸, Á¶»ç 2. °Ë»ç, °Ë»ö
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
single blinding study
´Ü¼ø¸Í°Ë¹ý
urodynamic study
¿ä¿ªµ¿Çа˻ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
family study
°¡Á·Á¶»ç
feasibility study
°¡´É¼º¿¬±¸
first pass study
ÀÏÂ÷Åë°ú°Ë»ç
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®Á¶»ç
intervening study
°³ÀÔ¿¬±¸
longitudinal study
ÃßÀû¿¬±¸
microbiologic study
¹Ì»ý¹°Çа˻ç
migrant study
ÀÌÁֹבּ¸
mixing study
È¥ÇÕ°Ë»ç
molecular genetic study
ºÐÀÚÀ¯ÀüÇа˻ç
neurophysiological study
½Å°æ»ý¸®ÇÐÀû°Ë»ç
nonconcurrent study
ºñµ¿½ÃÀû¿¬±¸
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ½ÇÇè
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
African horse sickness virus
¾ÆÇÁ¸®Ä« ¸»º´¹ÙÀÌ·¯½º
African sleeping sickness
¾ÆÇÁ¸®Ä«¼ö¸éº´(~â²ØùÜ»)
African swine fever virus
¾ÆÇÁ¸®Ä« µÅÁö¿¹ÙÀÌ·¯½º
African tick fever
¾ÆÇÁ¸®Ä« Áøµå±â¿.
African tick fever
¾ÆÇÁ¸®Ä«Áøµå±â¿
East African sleeping sickness
µ¿ºÎ¾ÆÇÁ¸®Ä«¼ö¸éº´.
South African tick bite fever
³²¾ÆÇÁ¸®Ä«Á»Áøµå±â¿.
South African tick bite fever
³²¾ÆÇÁ¸®Ä«Á»Áøµå±â¿.
african kaposis sarcoma
¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡ë¿ðþ)
african sleeping disease
¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡â²ØùÜ»)
african sleeping sickness
¾ÆÇÁ¸®Ä«¼ö¸éº´
african trypanosomiasis
¾ÆÇÁ¸®Ä« Æ®¸®ÆÄ³ë¼Ò¸¶Áõ(¡ñø)
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
double-blind study
ÀÌÁ߸ͰË.
family study
°¡Á·Á¶»ç(¿¬±¸)
first pass study
ÀÏÂ÷Åë°ú°Ë»ç.
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®¿¬±¸
microbiologic study
¹Ì»ý¹°ÇÐÀû °Ë»ç
molecular genetic study
ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
nested case control study
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½